Thoracic endovascular aortic repair (TEVAR) is the preferred management for pathology of the descending thoracic aorta, including penetrating aortic ulcers, dissections, and blunt trauma. TEVAR often requires exclusion of the left subclavian artery to establish an adequate proximal landing zone.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Endovascular Techniques
August 21, 2025
As interventional techniques continue to gain popularity in cardiothoracic surgery, familiarity and mastery of these techniques are increasingly important for trainees and early career surgeons.
July 11, 2024
A cohort of 2145 patients from the International Registry of Acute Aortic Dissection were compared according to whether they had axillary (1106 [52 percent]) or femoral (1039 [48 percent]) arterial cannulation.
September 12, 2023
Survivors of Acute Stanford B (DeBakey III) in Holland: a patient-cantered follow-up indicating that the treatment strategy did not influence quality of life.
July 11, 2022
There could be some translational value for cardiovascular surgical practice from this prospective cardiovascular health study. The mechanistic link warrants further investigation and interpretation.
May 20, 2022
This is a compreshensive review on the experience with use of TEVAR in patients with Marfan syndrome, including durablity, complications, and timing, etc. Drs. Steinmetz and Cosellihe also discussed the role and trend of TEVAR in Marfan paitents with aortic disease.
April 20, 2022
On April 20, 2020, Terumo Aortic announced that the US FDA has granted approval for the Thoraflex Hybrid frozen elephant trunk prothesis.
This is the first FET prosthesis commercially available in the US and will bring a new viable treatment option for patients with diseases of the aortic arch and descending aorta.
February 28, 2022
An interesting brief editorial on an experiment revisiting renal denervation as a panacea to cardiovascular disease
February 26, 2022
This newly released AHA scientific statement offers a comprehensive review of the latest imaging and measurement techniques for patients with chronic aortic dissection and clarifies the need for standardized measurements and reporting for lifelong surveillance.
February 18, 2022
The American Heart Association has released a scientific statement on imaging and surveillance of chronic aortic dissection, expounding the state-of-the-art imaging and measurement techniques (CT, MR and echocardiography), and clarifying the need for standardized measurements and reporting for lifelong surveillance.